Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]Florbetapir PET for Demyelination in RRMS
NCT01767493Phase 4Completed
- Sponsor
- Institute for Neurodegenerative Disorders
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Florbetapir in relapsing-remitting multiple sclerosis (RRMS), sponsored by Institute for Neurodegenerative Disorders. Started Nov 2012; status: completed.
02
Drugs
Florbetapir
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01767493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767493.